Novo Nordisk manufactures and markets semaglutide, used to treat diabetes under the brand name Ozempic and obesity under the brand name Wegovy.
Continue reading Danish Company Owns Rights To Ozempic & Wegovy
By Julie Selesnick – Senior Counsel at Berger Montague
Since December 31 and the first attestation requirement for group health plans is fast approaching, I decided to take a look at how the major insurance carriers providing administrative services to self-funded plans are “helping” the plans with this requirement. I figured I would look at each of the larger carriers and report back to the benefits community on LinkedIn about how they were handling it.
Continue reading Cigna and its Terrible, Horrible, No Good, Very Bad Position on [NOT] Filing Attestations of Compliance on Behalf of Fully Insured Plan Clients